(Q28259929)

English

Phase I study of Rigosertib, an inhibitor of the phosphatidylinositol 3-kinase and Polo-like kinase 1 pathways, combined with gemcitabine in patients with solid tumors and pancreatic cancer

scientific article

Statements

Phase I study of Rigosertib, an inhibitor of the phosphatidylinositol 3-kinase and Polo-like kinase 1 pathways, combined with gemcitabine in patients with solid tumors and pancreatic cancer (English)
0 references
0 references
0 references
0 references
0 references
0 references
Wells A Messersmith
0 references
Colin D Weekes
0 references
Chen Ren
0 references
Manoj Maniar
0 references
Francois Wilhelm
0 references
Antonio Jimeno
0 references
1 April 2012
0 references
18
0 references
2048-55
0 references
7
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit